Megan C. del Valle, MPH | Psychiatrist.com

Original Research

Change in Framingham Risk Score in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, 6-Week Trial of Ziprasidone and Olanzapine

December 15, 2006

Megan C. del Valle, Antony D. Loebel, Stephen Murray Ruoyong, et al